BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sánchez-Lozada LG, Tapia E, Bautista-García P, Soto V, Avila-Casado C, Vega-Campos IP, Nakagawa T, Zhao L, Franco M, Johnson RJ. Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome. Am J Physiol Renal Physiol. 2008;294:F710-F718. [PMID: 18216151 DOI: 10.1152/ajprenal.00454.2007] [Cited by in Crossref: 112] [Cited by in F6Publishing: 107] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Johnson RJ, Sánchez-Lozada LG, Nakagawa T, Rodriguez-Iturbe B, Tolan D, Gaucher EA, Andrews P, Lanaspa MA. Do thrifty genes exist? Revisiting uricase. Obesity (Silver Spring) 2022;30:1917-26. [PMID: 36150210 DOI: 10.1002/oby.23540] [Reference Citation Analysis]
2 Guma M, Dadpey B, Coras R, Mikuls TR, Hamilton B, Quehenberger O, Thorisdottir H, Bittleman D, Lauro K, Reilly SM, Liu-Bryan R, Terkeltaub R. Xanthine oxidase inhibitor urate-lowering therapy titration to target decreases serum free fatty acids in gout and suppresses lipolysis by adipocytes. Arthritis Res Ther 2022;24:175. [PMID: 35879786 DOI: 10.1186/s13075-022-02852-4] [Reference Citation Analysis]
3 Janssen LE, Simons N, Simons PI, Schaper NC, Feskens EJ, van der Ploeg LM, Van den Eynde MD, Schalkwijk CG, Houben AJ, Stehouwer CD, Brouwers MC. Effects of fructose restriction on blood pressure: Secondary analysis of a double-blind randomized controlled trial. Clinical Nutrition ESPEN 2022. [DOI: 10.1016/j.clnesp.2022.07.009] [Reference Citation Analysis]
4 Xu L, Hu G, Qiu J, Fan Y, Ma Y, Miura T, Kohzuki M, Ito O. High Fructose-Induced Hypertension and Renal Damage Are Exaggerated in Dahl Salt-Sensitive Rats via Renal Renin-Angiotensin System Activation. J Am Heart Assoc 2021;10:e016543. [PMID: 34259014 DOI: 10.1161/JAHA.120.016543] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Nakamura T, Nampei M, Murase T, Satoh E, Akari S, Katoh N, Mizukami H. Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice. Nutr Diabetes 2021;11:12. [PMID: 33850106 DOI: 10.1038/s41387-021-00155-2] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Said MA, Nafeh NY, Abdallah HA. Spexin alleviates hypertension, hyperuricaemia, dyslipidemia and insulin resistance in high fructose diet induced metabolic syndrome in rats via enhancing PPAR-ɣ and AMPK and inhibiting IL-6 and TNF-α. Arch Physiol Biochem 2021;:1-6. [PMID: 33721543 DOI: 10.1080/13813455.2021.1899242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Pugliese NR, Mengozzi A, Virdis A, Casiglia E, Tikhonoff V, Cicero AFG, Ungar A, Rivasi G, Salvetti M, Barbagallo CM, Bombelli M, Dell'Oro R, Bruno B, Lippa L, D'Elia L, Verdecchia P, Mallamaci F, Cirillo M, Rattazzi M, Cirillo P, Gesualdo L, Mazza A, Giannattasio C, Maloberti A, Volpe M, Tocci G, Georgiopoulos G, Iaccarino G, Nazzaro P, Parati G, Palatini P, Galletti F, Ferri C, Desideri G, Viazzi F, Pontremoli R, Muiesan ML, Grassi G, Masi S, Borghi C; Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension. The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk. Clin Res Cardiol 2021;110:1073-82. [PMID: 33604722 DOI: 10.1007/s00392-021-01815-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Saito H, Tanaka K, Iwasaki T, Oda A, Watanabe S, Kanno M, Kimura H, Shimabukuro M, Asahi K, Watanabe T, Kazama JJ. Xanthine oxidase inhibitors are associated with reduced risk of cardiovascular disease. Sci Rep 2021;11:1380. [PMID: 33446757 DOI: 10.1038/s41598-020-80835-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
9 Basnet R, Khadka S, Basnet BB, Basnet TB, Chidi BB, Nirala S, Gupta R, Sharma B. Xanthine Oxidase and Transforming Growth Factor Beta-activated Kinase 1: Potential Targets for Gout Intervention. Curr Rheumatol Rev 2021;17:153-61. [PMID: 33243128 DOI: 10.2174/1573397116666201126162202] [Reference Citation Analysis]
10 Taş F. Knowledge attitudes and behaviors of adult individuals about high fructose corn syrup consumption; cross sectional survey study. Clin Nutr ESPEN 2020;40:179-86. [PMID: 33183534 DOI: 10.1016/j.clnesp.2020.09.025] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Hieronimus B, Medici V, Bremer AA, Lee V, Nunez MV, Sigala DM, Keim NL, Havel PJ, Stanhope KL. Synergistic effects of fructose and glucose on lipoprotein risk factors for cardiovascular disease in young adults. Metabolism 2020;112:154356. [PMID: 32916151 DOI: 10.1016/j.metabol.2020.154356] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
12 Hussein AMS, Fouda K, Mehaya FM, Mohamed DA, Mohammad AA, Abdelgayed SS, Mohamed RS. Fortified vegetarian milk for prevention of metabolic syndrome in rats: impact on hepatic and vascular complications. Heliyon 2020;6:e04593. [PMID: 32793828 DOI: 10.1016/j.heliyon.2020.e04593] [Reference Citation Analysis]
13 Merino B, Fernández-Díaz CM, Cózar-Castellano I, Perdomo G. Intestinal Fructose and Glucose Metabolism in Health and Disease. Nutrients 2019;12:E94. [PMID: 31905727 DOI: 10.3390/nu12010094] [Cited by in Crossref: 16] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
14 García-Arroyo FE, Monroy-Sánchez F, Muñoz-Jiménez I, Gonzaga G, Andrés-Hernando A, Zazueta C, Juárez-Rojas JG, Lanaspa MA, Johnson RJ, Sánchez-Lozada LG. Allopurinol Prevents the Lipogenic Response Induced by an Acute Oral Fructose Challenge in Short-Term Fructose Fed Rats. Biomolecules 2019;9:E601. [PMID: 31614639 DOI: 10.3390/biom9100601] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
15 Li S, Li L, Yan H, Jiang X, Hu W, Han N, Wang D. Anti‑gouty arthritis and anti‑hyperuricemia properties of celery seed extracts in rodent models. Mol Med Rep 2019;20:4623-33. [PMID: 31702020 DOI: 10.3892/mmr.2019.10708] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
16 Olaniyi KS, Olatunji LA. Glutamine confers renoprotection by normalizing lipid and glutathione content in insulin-resistant pregnant rats. Chemico-Biological Interactions 2019;310:108721. [DOI: 10.1016/j.cbi.2019.06.034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
17 Wu J, Zhang YP, Qu Y, Jie LG, Deng JX, Yu QH. Efficacy of uric acid-lowering therapy on hypercholesterolemia and hypertriglyceridemia in gouty patients. Int J Rheum Dis 2019;22:1445-51. [PMID: 31317680 DOI: 10.1111/1756-185X.13652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
18 Funcke JB, Scherer PE. Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication. J Lipid Res 2019;60:1648-84. [PMID: 31209153 DOI: 10.1194/jlr.R094060] [Cited by in Crossref: 57] [Cited by in F6Publishing: 88] [Article Influence: 19.0] [Reference Citation Analysis]
19 Eliseev MS, Novikova AM. [Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy]. Ter Arkh 2019;91:120-8. [PMID: 32598686 DOI: 10.26442/00403660.2019.05.000232] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Edwards A, Auberson M, Ramakrishnan SK, Bonny O. A model of uric acid transport in the rat proximal tubule. American Journal of Physiology-Renal Physiology 2019;316:F934-47. [DOI: 10.1152/ajprenal.00603.2018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
21 Harmon DB, Mandler WK, Sipula IJ, Dedousis N, Lewis SE, Eckels JT, Du J, Wang Y, Huckestein BR, Pagano PJ, Cifuentes-Pagano E, Homanics GE, Van't Erve TJ, Stefanovic-Racic M, Jurczak MJ, O'Doherty RM, Kelley EE. Hepatocyte-Specific Ablation or Whole-Body Inhibition of Xanthine Oxidoreductase in Mice Corrects Obesity-Induced Systemic Hyperuricemia Without Improving Metabolic Abnormalities. Diabetes 2019;68:1221-9. [PMID: 30936145 DOI: 10.2337/db18-1198] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
22 Park SK, Rosenthal TR, Williams JS, Shelton JM, Takahashi M, Zhang S, Bobulescu IA. Metabolic and cardiovascular effects of chronic mild hyperuricemia in rodents. J Investig Med 2018;66:1037-44. [PMID: 30042113 DOI: 10.1136/jim-2018-000729] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Battelli MG, Bortolotti M, Polito L, Bolognesi A. The role of xanthine oxidoreductase and uric acid in metabolic syndrome. Biochim Biophys Acta Mol Basis Dis 2018;1864:2557-65. [PMID: 29733945 DOI: 10.1016/j.bbadis.2018.05.003] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 10.3] [Reference Citation Analysis]
24 Orlando A, Cazzaniga E, Giussani M, Palestini P, Genovesi S. Hypertension in Children: Role of Obesity, Simple Carbohydrates, and Uric Acid. Front Public Health 2018;6:129. [PMID: 29774210 DOI: 10.3389/fpubh.2018.00129] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
25 Marin M, Maalouf NM. Effects of pharmacological reversal of hyperuricemia on features of the metabolic syndrome in patients with gouty arthritis. J Investig Med 2018;66:1031-6. [PMID: 29622755 DOI: 10.1136/jim-2018-000728] [Reference Citation Analysis]
26 Latourte A, Bardin T, Clerson P, Ea H, Flipo R, Richette P. Dyslipidemia, Alcohol Consumption, and Obesity as Main Factors Associated With Poor Control of Urate Levels in Patients Receiving Urate-Lowering Therapy. Arthritis Care Res 2018;70:918-24. [DOI: 10.1002/acr.23347] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
27 Kim S. Interrelationship of Uric Acid, Gout, and Metabolic Syndrome: Focus on Hypertension, Cardiovascular Disease, and Insulin Resistance. J Rheum Dis 2018;25:19. [DOI: 10.4078/jrd.2018.25.1.19] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
28 Castro VMFD, Melo ACD, Belo VS, Chaves VE. Effect of allopurinol and uric acid normalization on serum lipids hyperuricemic subjects: A systematic review with meta-analysis. Clinical Biochemistry 2017;50:1289-97. [DOI: 10.1016/j.clinbiochem.2017.07.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 García-Arroyo FE, Tapia E, Blas-Marron MG, Gonzaga G, Silverio O, Cristóbal M, Osorio H, Arellano-Buendía AS, Zazueta C, Aparicio-Trejo OE, Reyes-García JG, Pedraza-Chaverri J, Soto V, Roncal-Jiménez C, Johnson RJ, Sánchez-Lozada LG. Vasopressin Mediates the Renal Damage Induced by Limited Fructose Rehydration in Recurrently Dehydrated Rats. Int J Biol Sci 2017;13:961-75. [PMID: 28924378 DOI: 10.7150/ijbs.20074] [Cited by in Crossref: 27] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
30 Nurdiana S, Goh YM, Ahmad H, Dom SM, Syimal'ain Azmi N, Noor Mohamad Zin NS, Ebrahimi M. Changes in pancreatic histology, insulin secretion and oxidative status in diabetic rats following treatment with Ficus deltoidea and vitexin. BMC Complement Altern Med 2017;17:290. [PMID: 28576138 DOI: 10.1186/s12906-017-1762-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 8.0] [Reference Citation Analysis]
31 Johnson RJ, Sánchez-Lozada LG, Andrews P, Lanaspa MA. Perspective: A Historical and Scientific Perspective of Sugar and Its Relation with Obesity and Diabetes. Adv Nutr 2017;8:412-22. [PMID: 28507007 DOI: 10.3945/an.116.014654] [Cited by in Crossref: 44] [Cited by in F6Publishing: 53] [Article Influence: 8.8] [Reference Citation Analysis]
32 Legeza B, Marcolongo P, Gamberucci A, Varga V, Bánhegyi G, Benedetti A, Odermatt A. Fructose, Glucocorticoids and Adipose Tissue: Implications for the Metabolic Syndrome. Nutrients 2017;9:E426. [PMID: 28445389 DOI: 10.3390/nu9050426] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
33 Ran J, Xu G, Ma H, Xu H, Liu Y, Tan R, Zhu P, Song J, Lao G. Febuxostat Attenuates Renal Damage besides Exerting Hypouricemic Effect in Streptozotocin-Induced Diabetic Rats. Int J Nephrol 2017;2017:2739539. [PMID: 28503330 DOI: 10.1155/2017/2739539] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
34 Ranjith N, Myeni NN, Sartorius B, Mayise C. Association Between Hyperuricemia and Major Adverse Cardiac Events in Patients with Acute Myocardial Infarction. Metabolic Syndrome and Related Disorders 2017;15:18-25. [DOI: 10.1089/met.2016.0032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
35 Xu C, Lu A, Lu X, Zhang L, Fang H, Zhou L, Yang T. Activation of Renal (Pro)Renin Receptor Contributes to High Fructose-Induced Salt Sensitivity. Hypertension 2017;69:339-48. [PMID: 27993957 DOI: 10.1161/HYPERTENSIONAHA.116.08240] [Cited by in Crossref: 39] [Cited by in F6Publishing: 48] [Article Influence: 6.5] [Reference Citation Analysis]
36 Kushiyama A, Nakatsu Y, Matsunaga Y, Yamamotoya T, Mori K, Ueda K, Inoue Y, Sakoda H, Fujishiro M, Ono H, Asano T. Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis. Mediators Inflamm 2016;2016:8603164. [PMID: 28070145 DOI: 10.1155/2016/8603164] [Cited by in Crossref: 45] [Cited by in F6Publishing: 53] [Article Influence: 7.5] [Reference Citation Analysis]
37 Wider MD. Metabolic syndrome and the hepatorenal reflex. Surg Neurol Int 2016;7:99. [PMID: 28168086 DOI: 10.4103/2152-7806.194147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
38 Peleli M, Zollbrecht C, Montenegro MF, Hezel M, Zhong J, Persson EG, Holmdahl R, Weitzberg E, Lundberg JO, Carlström M. Enhanced XOR activity in eNOS-deficient mice. Free Radical Biology and Medicine 2016;99:472-84. [DOI: 10.1016/j.freeradbiomed.2016.09.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
39 Wider MD. Metabolic syndrome and the hepatorenal reflex. Surg Neurol Int 2016;7:83. [PMID: 27656314 DOI: 10.4103/2152-7806.190438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
40 Steubl D, Michel MC. Experimental and clinical nephroprotection by the xanthine oxidase inhibitor febuxostat. Naunyn Schmiedebergs Arch Pharmacol 2016;389:815-7. [PMID: 27220331 DOI: 10.1007/s00210-016-1260-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Roncal-Jimenez CA, Ishimoto T, Lanaspa MA, Milagres T, Hernando AA, Jensen T, Miyazaki M, Doke T, Hayasaki T, Nakagawa T, Marumaya S, Long DA, Garcia GE, Kuwabara M, Sánchez-Lozada LG, Kang DH, Johnson RJ. Aging-associated renal disease in mice is fructokinase dependent. Am J Physiol Renal Physiol 2016;311:F722-30. [PMID: 27465991 DOI: 10.1152/ajprenal.00306.2016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
42 Komers R, Xu B, Schneider J, Oyama TT. Effects of xanthine oxidase inhibition with febuxostat on the development of nephropathy in experimental type 2 diabetes. Br J Pharmacol 2016;173:2573-88. [PMID: 27238746 DOI: 10.1111/bph.13527] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
43 Cheung YT, Edelmann MN, Mulrooney DA, Green DM, Chemaitilly W, John N, Robison LL, Hudson MM, Krull KR. Uric Acid and Neurocognitive Function in Survivors of Childhood Acute Lymphoblastic Leukemia Treated with Chemotherapy Only. Cancer Epidemiol Biomarkers Prev 2016;25:1259-67. [PMID: 27345588 DOI: 10.1158/1055-9965.EPI-16-0118] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
44 Fahmi ANA, Shehatou GSG, Shebl AM, Salem HA. Febuxostat exerts dose-dependent renoprotection in rats with cisplatin-induced acute renal injury. Naunyn-Schmiedeberg's Arch Pharmacol 2016;389:819-30. [DOI: 10.1007/s00210-016-1258-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
45 Shirakura T, Nomura J, Matsui C, Kobayashi T, Tamura M, Masuzaki H. Febuxostat, a novel xanthine oxidoreductase inhibitor, improves hypertension and endothelial dysfunction in spontaneously hypertensive rats. Naunyn Schmiedebergs Arch Pharmacol 2016;389:831-8. [PMID: 27198514 DOI: 10.1007/s00210-016-1239-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
46 Klein AV, Kiat H. The mechanisms underlying fructose-induced hypertension: a review. J Hypertens 2015;33:912-20. [PMID: 25715094 DOI: 10.1097/HJH.0000000000000551] [Cited by in Crossref: 63] [Cited by in F6Publishing: 31] [Article Influence: 10.5] [Reference Citation Analysis]
47 García-Arroyo FE, Cristóbal M, Arellano-Buendía AS, Osorio H, Tapia E, Soto V, Madero M, Lanaspa MA, Roncal-Jiménez C, Bankir L, Johnson RJ, Sánchez-Lozada LG. Rehydration with soft drink-like beverages exacerbates dehydration and worsens dehydration-associated renal injury. Am J Physiol Regul Integr Comp Physiol 2016;311:R57-65. [PMID: 27053647 DOI: 10.1152/ajpregu.00354.2015] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 6.8] [Reference Citation Analysis]
48 Kanbay M, Jensen T, Solak Y, Le M, Roncal-Jimenez C, Rivard C, Lanaspa MA, Nakagawa T, Johnson RJ. Uric acid in metabolic syndrome: From an innocent bystander to a central player. Eur J Intern Med 2016;29:3-8. [PMID: 26703429 DOI: 10.1016/j.ejim.2015.11.026] [Cited by in Crossref: 156] [Cited by in F6Publishing: 143] [Article Influence: 22.3] [Reference Citation Analysis]
49 Dornas WC, de Lima WG, Pedrosa ML, Silva ME. Health implications of high-fructose intake and current research. Adv Nutr 2015;6:729-37. [PMID: 26567197 DOI: 10.3945/an.114.008144] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 7.9] [Reference Citation Analysis]
50 Kim Y, Shin S, Kim K, Choi S, Lee K. Effect of Urate Lowering Therapy on Renal Disease Progression in Hyperuricemic Patients with Chronic Kidney Disease. J Rheumatol 2015;42:2143-8. [PMID: 26428209 DOI: 10.3899/jrheum.150067] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
51 Lu W, Xu Y, Shao X, Gao F, Li Y, Hu J, Zuo Z, Shao X, Zhou L, Zhao Y, Cen X. Uric Acid Produces an Inflammatory Response through Activation of NF-κB in the Hypothalamus: Implications for the Pathogenesis of Metabolic Disorders. Sci Rep 2015;5:12144. [PMID: 26179594 DOI: 10.1038/srep12144] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
52 Lima WG, Martins-Santos ME, Chaves VE. Uric acid as a modulator of glucose and lipid metabolism. Biochimie 2015;116:17-23. [PMID: 26133655 DOI: 10.1016/j.biochi.2015.06.025] [Cited by in Crossref: 94] [Cited by in F6Publishing: 107] [Article Influence: 13.4] [Reference Citation Analysis]
53 Greenberg KI, McAdams-DeMarco MA, Köttgen A, Appel LJ, Coresh J, Grams ME. Plasma Urate and Risk of a Hospital Stay with AKI: The Atherosclerosis Risk in Communities Study. Clin J Am Soc Nephrol 2015;10:776-83. [PMID: 25717072 DOI: 10.2215/CJN.05870614] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
54 Tanaka K, Nakayama M, Kanno M, Kimura H, Watanabe K, Tani Y, Hayashi Y, Asahi K, Terawaki H, Watanabe T. Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial. Clin Exp Nephrol 2015;19:1044-53. [PMID: 25676011 DOI: 10.1007/s10157-015-1095-1] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 7.9] [Reference Citation Analysis]
55 Peng TC, Wang CC, Kao TW, Chan JY, Yang YH, Chang YW, Chen WL. Relationship between hyperuricemia and lipid profiles in US adults. Biomed Res Int. 2015;2015:127596. [PMID: 25629033 DOI: 10.1155/2015/127596] [Cited by in Crossref: 58] [Cited by in F6Publishing: 92] [Article Influence: 8.3] [Reference Citation Analysis]
56 Perez-Ruiz F, Dalbeth N, Bardin T. A review of uric acid, crystal deposition disease, and gout. Adv Ther 2015;32:31-41. [PMID: 25533440 DOI: 10.1007/s12325-014-0175-z] [Cited by in Crossref: 135] [Cited by in F6Publishing: 107] [Article Influence: 19.3] [Reference Citation Analysis]
57 DiNicolantonio JJ, Lucan SC. The wrong white crystals: not salt but sugar as aetiological in hypertension and cardiometabolic disease. Open Heart 2014;1:e000167. [PMID: 25717381 DOI: 10.1136/openhrt-2014-000167] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 6.1] [Reference Citation Analysis]
58 Feig DI. Serum uric acid and the risk of hypertension and chronic kidney disease. Curr Opin Rheumatol. 2014;26:176-185. [PMID: 24419747 DOI: 10.1097/bor.0000000000000033] [Cited by in Crossref: 55] [Cited by in F6Publishing: 32] [Article Influence: 6.9] [Reference Citation Analysis]
59 Mahmoud AA, Elshazly SM. Ursodeoxycholic acid ameliorates fructose-induced metabolic syndrome in rats. PLoS One 2014;9:e106993. [PMID: 25202970 DOI: 10.1371/journal.pone.0106993] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
60 Richette P, Perez-Ruiz F, Doherty M, Jansen TL, Nuki G, Pascual E, Punzi L, So AK, Bardin T. Improving cardiovascular and renal outcomes in gout: what should we target? Nat Rev Rheumatol. 2014;10:654-661. [PMID: 25136785 DOI: 10.1038/nrrheum.2014.124] [Cited by in Crossref: 100] [Cited by in F6Publishing: 108] [Article Influence: 12.5] [Reference Citation Analysis]
61 Lee HJ, Jeong KH, Kim YG, Moon JY, Lee SH, Ihm CG, Sung JY, Lee TW. Febuxostat ameliorates diabetic renal injury in a streptozotocin-induced diabetic rat model. Am J Nephrol 2014;40:56-63. [PMID: 25034030 DOI: 10.1159/000363421] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 5.9] [Reference Citation Analysis]
62 Sattui SE, Singh JA, Gaffo AL. Comorbidities in patients with crystal diseases and hyperuricemia. Rheum Dis Clin North Am 2014;40:251-78. [PMID: 24703346 DOI: 10.1016/j.rdc.2014.01.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
63 Viazzi F, Leoncini G, Ratto E, Pontremoli R. Hyperuricemia and Renal Risk. High Blood Press Cardiovasc Prev 2014;21:189-94. [DOI: 10.1007/s40292-014-0042-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
64 Ryu KA, Kang HH, Kim SY, Yoo MK, Kim JS, Lee CH, Wie GA. Comparison of nutrient intake and diet quality between hyperuricemia subjects and controls in Korea. Clin Nutr Res 2014;3:56-63. [PMID: 24527421 DOI: 10.7762/cnr.2014.3.1.56] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
65 Aydin S, Aksoy A, Aydin S, Kalayci M, Yilmaz M, Kuloglu T, Citil C, Catak Z. Today's and yesterday's of pathophysiology: Biochemistry of metabolic syndrome and animal models. Nutrition 2014;30:1-9. [DOI: 10.1016/j.nut.2013.05.013] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 8.5] [Reference Citation Analysis]
66 Soltani Z, Rasheed K, Kapusta DR, Reisin E. Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Curr Hypertens Rep 2013;15:175-81. [PMID: 23588856 DOI: 10.1007/s11906-013-0344-5] [Cited by in Crossref: 120] [Cited by in F6Publishing: 115] [Article Influence: 13.3] [Reference Citation Analysis]
67 Koppe L, Pelletier CC, Alix PM, Kalbacher E, Fouque D, Soulage CO, Guebre-Egziabher F. Insulin resistance in chronic kidney disease: new lessons from experimental models. Nephrol Dial Transplant. 2014;29:1666-1674. [PMID: 24286973 DOI: 10.1093/ndt/gft435] [Cited by in Crossref: 37] [Cited by in F6Publishing: 46] [Article Influence: 4.1] [Reference Citation Analysis]
68 Fenske W, Athanasiou T, Harling L, Drechsler C, Darzi A, Ashrafian H. Obesity-related cardiorenal disease: the benefits of bariatric surgery. Nat Rev Nephrol 2013;9:539-51. [PMID: 23917797 DOI: 10.1038/nrneph.2013.145] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
69 Tsushima Y, Nishizawa H, Tochino Y, Nakatsuji H, Sekimoto R, Nagao H, Shirakura T, Kato K, Imaizumi K, Takahashi H. Uric acid secretion from adipose tissue and its increase in obesity. J Biol Chem. 2013;288:27138-27149. [PMID: 23913681 DOI: 10.1074/jbc.m113.485094] [Cited by in Crossref: 146] [Cited by in F6Publishing: 172] [Article Influence: 16.2] [Reference Citation Analysis]
70 Savarese G, Ferri C, Trimarco B, Rosano G, Dellegrottaglie S, Losco T, Casaretti L, D'amore C, Gambardella F, Prastaro M, Rengo G, Leosco D, Perrone-filardi P. Changes in serum uric acid levels and cardiovascular events: A meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases 2013;23:707-14. [DOI: 10.1016/j.numecd.2013.03.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
71 Levantesi G, Marfisi RM, Franzosi MG, Maggioni AP, Nicolosi GL, Schweiger C, Silletta MG, Tavazzi L, Tognoni G, Marchioli R. Uric acid: A cardiovascular risk factor in patients with recent myocardial infarction. International Journal of Cardiology 2013;167:262-9. [DOI: 10.1016/j.ijcard.2011.12.110] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
72 Oda E. Serum uric acid is an independent predictor of metabolic syndrome in a Japanese health screening population. Heart Vessels 2014;29:496-503. [DOI: 10.1007/s00380-013-0386-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
73 Kivity S, Kopel E, Steinlauf S, Segev S, Sidi Y, Olchovsky D. The association between serum uric acid and diabetes mellitus is stronger in women. J Womens Health (Larchmt) 2013;22:782-9. [PMID: 23805880 DOI: 10.1089/jwh.2012.4043] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
74 Johnson RJ, Nakagawa T, Jalal D, Sánchez-Lozada LG, Kang DH, Ritz E. Uric acid and chronic kidney disease: which is chasing which? Nephrol Dial Transplant. 2013;28:2221-2228. [PMID: 23543594 DOI: 10.1093/ndt/gft029] [Cited by in Crossref: 284] [Cited by in F6Publishing: 294] [Article Influence: 31.6] [Reference Citation Analysis]
75 Szasz T, Davis RP, Garver HS, Burnett RJ, Fink GD, Watts SW. Long-term inhibition of xanthine oxidase by febuxostat does not decrease blood pressure in deoxycorticosterone acetate (DOCA)-salt hypertensive rats. PLoS One 2013;8:e56046. [PMID: 23393607 DOI: 10.1371/journal.pone.0056046] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
76 Oudot C, Lajoix AD, Jover B, Rugale C. Dietary sodium restriction prevents kidney damage in high fructose-fed rats. Kidney Int 2013;83:674-83. [PMID: 23344470 DOI: 10.1038/ki.2012.478] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
77 Tapia E, Cristóbal M, García-Arroyo FE, Soto V, Monroy-Sánchez F, Pacheco U, Lanaspa MA, Roncal-Jiménez CA, Cruz-Robles D, Ishimoto T, Madero M, Johnson RJ, Sánchez-Lozada LG. Synergistic effect of uricase blockade plus physiological amounts of fructose-glucose on glomerular hypertension and oxidative stress in rats. Am J Physiol Renal Physiol 2013;304:F727-36. [PMID: 23303409 DOI: 10.1152/ajprenal.00485.2012] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
78 Keenan T, Blaha MJ, Nasir K, Silverman MG, Tota-Maharaj R, Carvalho JA, Conceição RD, Blumenthal RS, Santos RD. Relation of uric acid to serum levels of high-sensitivity C-reactive protein, triglycerides, and high-density lipoprotein cholesterol and to hepatic steatosis. Am J Cardiol 2012;110:1787-92. [PMID: 22975466 DOI: 10.1016/j.amjcard.2012.08.012] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 5.4] [Reference Citation Analysis]
79 Simão AN, Lozovoy MA, Dichi I. The uric acid metabolism pathway as a therapeutic target in hyperuricemia related to metabolic syndrome. Expert Opin Ther Targets 2012;16:1175-87. [PMID: 23020656 DOI: 10.1517/14728222.2012.723694] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
80 Shafik AN. Febuxostat improves the local and remote organ changes induced by intestinal ischemia/reperfusion in rats. Dig Dis Sci. 2013;58:650-659. [PMID: 23010742 DOI: 10.1007/s10620-012-2391-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
81 Gaffo AL, Jacobs DR Jr, Sijtsma F, Lewis CE, Mikuls TR, Saag KG. Serum urate association with hypertension in young adults: analysis from the Coronary Artery Risk Development in Young Adults cohort. Ann Rheum Dis 2013;72:1321-7. [PMID: 22984170 DOI: 10.1136/annrheumdis-2012-201916] [Cited by in Crossref: 29] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
82 Zhou K, Kumar U, Yuen VG, Mcneill JH. The effects of phentolamine on fructose-fed rats. Can J Physiol Pharmacol 2012;90:1075-85. [DOI: 10.1139/y2012-063] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
83 Lanaspa MA, Tapia E, Soto V, Sautin Y, Sánchez-Lozada LG. Uric acid and fructose: potential biological mechanisms. Semin Nephrol. 2011;31:426-432. [PMID: 22000649 DOI: 10.1016/j.semnephrol.2011.08.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
84 Hu M, Tomlinson B. Febuxostat in the management of hyperuricemia and chronic gout: a review. Ther Clin Risk Manag 2008;4:1209-20. [PMID: 19337428 DOI: 10.2147/tcrm.s3310] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
85 Alvarez-Lario B, Macarrón-Vicente J. Is there anything good in uric acid? QJM 2011;104:1015-24. [PMID: 21908382 DOI: 10.1093/qjmed/hcr159] [Cited by in Crossref: 74] [Cited by in F6Publishing: 72] [Article Influence: 6.7] [Reference Citation Analysis]
86 Abdulla MH, Sattar MA, Johns EJ. The Relation between Fructose-Induced Metabolic Syndrome and Altered Renal Haemodynamic and Excretory Function in the Rat. Int J Nephrol 2011;2011:934659. [PMID: 21785727 DOI: 10.4061/2011/934659] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
87 Bardin T, Richette P. [The epidemiology and genetic of gout]. Presse Med. 2011;40:830-835. [PMID: 21752574 DOI: 10.1016/j.lpm.2011.04.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
88 Collino M. High dietary fructose intake: Sweet or bitter life? World J Diabetes 2011; 2(6): 77-81 [PMID: 21860690 DOI: 10.4239/wjd.v2.i6.77] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
89 Lin Y, Lai X, Chen G, Xu Y, Huang B, Wu Y, Chen Z, Yao L, Lin F, Qiao Y, Chen Z, Zhu S, Huang H, Wen J. Association among serum uric acid, cardiovascular risk, and arterial stiffness: a cross-sectional study in She ethnic minority group of Fujian Province in China. J Endocrinol Invest 2012;35:290-7. [PMID: 21646856 DOI: 10.3275/7765] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
90 Brymora A, Flisiński M, Johnson RJ, Goszka G, Stefańska A, Manitius J. Low-fructose diet lowers blood pressure and inflammation in patients with chronic kidney disease. Nephrol Dial Transplant 2012;27:608-12. [PMID: 21613382 DOI: 10.1093/ndt/gfr223] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 4.6] [Reference Citation Analysis]
91 Madero M, Perez-Pozo SE, Jalal D, Johnson RJ, Sánchez-Lozada LG. Dietary fructose and hypertension. Curr Hypertens Rep 2011;13:29-35. [PMID: 20957458 DOI: 10.1007/s11906-010-0163-x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 4.7] [Reference Citation Analysis]
92 Abdulla MH, Sattar MA, Johns EJ, Abdullah NA, Khan MA. Evidence for the role of α1A-adrenoceptor subtype in the control of renal haemodynamics in fructose-fed Sprague-Dawley rat. Eur J Nutr 2011;50:689-97. [PMID: 21373947 DOI: 10.1007/s00394-011-0180-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
93 Johnson RJ, Sanchez-Lozada LG, Nakagawa T. The effect of fructose on renal biology and disease. J Am Soc Nephrol 2010;21:2036-9. [PMID: 21115612 DOI: 10.1681/ASN.2010050506] [Cited by in Crossref: 106] [Cited by in F6Publishing: 97] [Article Influence: 8.8] [Reference Citation Analysis]
94 Dubchak N, Falasca GF. New and improved strategies for the treatment of gout. Int J Nephrol Renovasc Dis 2010;3:145-66. [PMID: 21694941 DOI: 10.2147/IJNRD.S6048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
95 Palanisamy N, Viswanathan P, Ravichandran MK, Anuradha CV. Renoprotective and blood pressure-lowering effect of dietary soy protein via protein kinase C beta II inhibition in a rat model of metabolic syndrome. Can J Physiol Pharmacol. 2010;88:28-37. [PMID: 20130736 DOI: 10.1139/y09-110] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
96 Inokuchi T, Tsutsumi Z, Takahashi S, Ka T, Moriwaki Y, Yamamoto T. Increased frequency of metabolic syndrome and its individual metabolic abnormalities in Japanese patients with primary gout. J Clin Rheumatol 2010;16:109-12. [PMID: 20375819 DOI: 10.1097/RHU.0b013e3181c6802e] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
97 Johnson RJ, Murray R. Fructose, Exercise, and Health: . Current Sports Medicine Reports 2010;9:253-8. [DOI: 10.1249/jsr.0b013e3181e7def4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
98 See LC, Kuo CF, Chuang FH, Shen YM, Ko YS, Chen YM, Yu KH. Hyperuricemia and metabolic syndrome: associations with chronic kidney disease. Clin Rheumatol 2011;30:323-30. [PMID: 20411291 DOI: 10.1007/s10067-010-1461-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
99 Nakayama T, Kosugi T, Gersch M, Connor T, Sanchez-Lozada LG, Lanaspa MA, Roncal C, Perez-Pozo SE, Johnson RJ, Nakagawa T. Dietary fructose causes tubulointerstitial injury in the normal rat kidney. Am J Physiol Renal Physiol 2010;298:F712-20. [PMID: 20071464 DOI: 10.1152/ajprenal.00433.2009] [Cited by in Crossref: 111] [Cited by in F6Publishing: 105] [Article Influence: 9.3] [Reference Citation Analysis]
100 Roncal CA, Reungjui S, Sánchez-Lozada LG, Mu W, Sautin YY, Nakagawa T, Johnson RJ. Combination of captopril and allopurinol retards fructose-induced metabolic syndrome. Am J Nephrol 2009;30:399-404. [PMID: 19696478 DOI: 10.1159/000235731] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
101 Gaffo AL, Edwards NL, Saag KG. Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link? Arthritis Res Ther 2009;11:240. [PMID: 19725932 DOI: 10.1186/ar2761] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
102 Sánchez-Lozada LG, Mu W, Roncal C, Sautin YY, Abdelmalek M, Reungjui S, Le M, Nakagawa T, Lan HY, Yu X, Johnson RJ. Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver. Eur J Nutr 2010;49:1-9. [PMID: 19626358 DOI: 10.1007/s00394-009-0042-x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
103 Hu QH, Wang C, Li JM, Zhang DM, Kong LD. Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: renal organic ion transporter involvement. Am J Physiol Renal Physiol 2009;297:F1080-91. [PMID: 19605544 DOI: 10.1152/ajprenal.90767.2008] [Cited by in Crossref: 74] [Cited by in F6Publishing: 73] [Article Influence: 5.7] [Reference Citation Analysis]
104 Tran LT, Yuen VG, McNeill JH. The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension. Mol Cell Biochem. 2009;332:145-159. [PMID: 19536638 DOI: 10.1007/s11010-009-0184-4] [Cited by in Crossref: 233] [Cited by in F6Publishing: 218] [Article Influence: 17.9] [Reference Citation Analysis]
105 See LC, Kuo CF, Chuang FH, Li HY, Chen YM, Chen HW, Yu KH. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate. J Rheumatol 2009;36:1691-8. [PMID: 19531754 DOI: 10.3899/jrheum.081199] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
106 Johnson RJ, Perez-Pozo SE, Sautin YY, Manitius J, Sanchez-Lozada LG, Feig DI, Shafiu M, Segal M, Glassock RJ, Shimada M, Roncal C, Nakagawa T. Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev 2009;30:96-116. [PMID: 19151107 DOI: 10.1210/er.2008-0033] [Cited by in Crossref: 303] [Cited by in F6Publishing: 299] [Article Influence: 23.3] [Reference Citation Analysis]
107 Shin YT, Kim KK, Hwang IC. Clinical Implication of Plasma Uric Acid Level. Korean J Fam Med 2009;30:670. [DOI: 10.4082/kjfm.2009.30.9.670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
108 Menè P, Punzo G. Uric acid: bystander or culprit in hypertension and progressive renal disease? J Hypertens 2008;26:2085-92. [PMID: 18854744 DOI: 10.1097/HJH.0b013e32830e4945] [Cited by in Crossref: 75] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
109 Gaffo AL, Saag KG. Management of hyperuricemia and gout in CKD. Am J Kidney Dis 2008;52:994-1009. [PMID: 18971014 DOI: 10.1053/j.ajkd.2008.07.035] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
110 Li J, Wang C, Hu Q, Kong L. Fructose Induced Leptin Dysfunction and Improvement by Quercetin and Rutin in Rats. Chinese Journal of Natural Medicines 2008;6:466-73. [DOI: 10.1016/s1875-5364(09)60038-8] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
111 Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359:1811-1821. [PMID: 18946066 DOI: 10.1056/nejmra0800885] [Cited by in Crossref: 1384] [Cited by in F6Publishing: 1480] [Article Influence: 98.9] [Reference Citation Analysis]
112 Perez-ruiz F, Dalbeth N, Schlesinger N. Febuxostat, a novel drug for the treatment of hyperuricemia of gout. Future Rheumatology 2008;3:421-7. [DOI: 10.2217/17460816.3.5.421] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
113 Johnson RJ, Sautin YY, Oliver WJ, Roncal C, Mu W, Gabriela Sanchez-Lozada L, Rodriguez-Iturbe B, Nakagawa T, Benner SA. Lessons from comparative physiology: could uric acid represent a physiologic alarm signal gone awry in western society? J Comp Physiol B 2009;179:67-76. [PMID: 18649082 DOI: 10.1007/s00360-008-0291-7] [Cited by in Crossref: 86] [Cited by in F6Publishing: 77] [Article Influence: 6.1] [Reference Citation Analysis]
114 Douard V, Ferraris RP. Regulation of the fructose transporter GLUT5 in health and disease. Am J Physiol Endocrinol Metab. 2008;295:E227-E237. [PMID: 18398011 DOI: 10.1152/ajpendo.90245.2008] [Cited by in Crossref: 285] [Cited by in F6Publishing: 242] [Article Influence: 20.4] [Reference Citation Analysis]